EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus
В.Б. Цветков, Anna M. Varizhuk, Liubov I. Kozlovskaya, Анна А. Штро, Olga S. Lebedeva, Andrey B. Komissarov, Tatjana Vedekhina, Valentin A. Manuvera, Olga V. Zubkova, Artem V. Eremeev, Elena Y. Shustova, Galina E. Pozmogova, Dmitry Lioznov, Aydar A. Ishmukhametov, В. Н. Лазарев, Maria A. Lagarkova
Topics & Concepts
Vero cellMutantEpigallocatechin gallateVirusCytotoxicityIn vitroVirologyBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Viral replicationChemistryCoronavirus disease 2019 (COVID-19)GeneBiochemistryMedicinePolyphenolInfectious disease (medical specialty)AntioxidantDiseasePathologyTea Polyphenols and EffectsTryptophan and brain disordersSARS-CoV-2 and COVID-19 Research